2010
DOI: 10.1016/j.ica.2010.05.033
|View full text |Cite
|
Sign up to set email alerts
|

Formation and structure in aqueous solution of complexes between vanadium(V) and aminohydroxamic acids that potentiates vanadium’s insulinomimetic activity: l-glutamic γ-hydroxamic and l-aspartic-β-hydroxamic acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 27 publications
0
10
0
Order By: Relevance
“…1 Vanadates have been investigated for purposes as diverse as polymerisation catalysts, 2,3 nanofibres, 4,5 pH probes 6 and insulin mimetics. [7][8][9] In particular, the medicinal applications of vanadates have attracted a substantial amount of interest. In recent years, attention has been focused on vanadate complexes as insulin mimetics in the treatment of diabetes.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1 Vanadates have been investigated for purposes as diverse as polymerisation catalysts, 2,3 nanofibres, 4,5 pH probes 6 and insulin mimetics. [7][8][9] In particular, the medicinal applications of vanadates have attracted a substantial amount of interest. In recent years, attention has been focused on vanadate complexes as insulin mimetics in the treatment of diabetes.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, attention has been focused on vanadate complexes as insulin mimetics in the treatment of diabetes. [7][8][9][10][11][12] Several vanadium chemistry reviews have been published in the last decade describing these investigations. [13][14][15][16] For the application and/or investigation of vanadates and vanadate complexes in aqueous solution, a thorough understanding of the solution chemistry is essential.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, [V(ma) 2 (N-N)][ClO 4 ] (N-N = bpy, phen, dpq, dppz) and vanadium(V) complexes bearing aspartic-b-and glutamic-g-hydroxamic acid as ligands, were examined for insulin mimetic activity. 76,77 The antidiabetic characteristics of [VO(dmpp) 2 ], [VO(pimin) 2 ], [VO(Etpimin) 2 ] and [VO(EtOHpimin) 2 ] were assessed (dmpp = bis(1,2-dimethyl-3-hydroxy-4pyridinonate), piminH = 2-(2 0 -hydroxyphenyl)-1H-imidazoline, EtpiminH = 2-(2 0 -hydroxyphenyl)-1-ethylimidazoline, EtOHpimin = 2-(2 0 -hydroxyphenyl)-1-ethanolimidazoline). 78,79 The biotransformation of insulin-enhancing vanadium complexes, [VO(6-mepci) 2 ], [cis-{VO(pic) 2 (H 2 O)], [VO(acac) 2 ] and [VO(dhp) 2 ], were examined (6-mepci-H = 6-methylpicolinic acid, dhp-H = 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone).…”
Section: Biological and Medicinal Chemistrymentioning
confidence: 99%
“…Indeed, vanadate and vanadate complexes have been found to both activate and inhibit phosphate metabolising enzymes [8]. In recent years, attention has been focused on the medicinal applications of vanadates [9], particularly their potential as insulin mimetics in the treatment of diabetes [10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…A wide range of different types of vanadate complexes have been investigated to date, including those with amino alcohols, alcohols and amino acids, amongst others [10,[13][14][15][16][17][18][19][20]. These studies focused primarily on the determination of equilibrium constants under biologically relevant conditions and the identification of structural features which influence the stability of the complexes.…”
Section: Introductionmentioning
confidence: 99%